HotSpot Therapeutics
Founded 2017 · 57 employees on LinkedIn · 9 known investors
Find your way into HotSpot Therapeutics
HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies. The company serves patients requiring advanced therapeutic interventions.
Founders & leadership
Board

Investors · 9
How we know: Atlas Venture's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: B Capital Group's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: MRL Ventures Fund's portfolio page · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: SR One Capital Management's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$100M disclosed across 1 of 3 rounds · 2020–2021
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through HotSpot Therapeutics went on to found or lead other companies.
Competitors · 1
by search overlapCompanies competing with HotSpot Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does HotSpot Therapeutics do?
- HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies. The company serves patients requiring advanced therapeutic interventions.
- Who are HotSpot Therapeutics's investors?
- HotSpot Therapeutics's investors include Atlas Venture, B Capital Group, B4 Capital, MRL Ventures Fund, Pivotal Life Sciences, Sofinnova Partners, Solasta Ventures, SR One Capital Management and 1 more.
- How much funding has HotSpot Therapeutics raised?
- HotSpot Therapeutics has disclosed $100M raised across 1 of its 3 known rounds.

.jpeg)




